基于细胞的非侵入性产前诊断用于囊性纤维化风险妊娠
本研究旨在开发针对囊性纤维化(CF)的基于细胞的非侵入性产前检测(NIPT),并在一例携带两种常见致病变异风险的妊娠中测试。孕妇为单绒毛膜双胎,夫妇均为F508del杂合携带者,伴侣还携带CFTR相关变异R117H。通过抗体富集和毛细管拾取仪从母血中分离胎儿滋养层细胞,进行多重PCR片段长度分析STR基因分型、胎儿性别和F508del状态,并用SNaPshot分析R117H。结果证实分离细胞为胎儿来源,检测到F508del杂合性和仅正常R117H等位基因,胎儿为健康携带者,与传统产前检测结果一致。
要点
- 基于细胞的NIPT可准确判断胎儿变异状态并区分胎儿滋养层与母体细胞。
- 在该双胎妊娠中,检测结果与传统产前检测一致,胎儿为F508del健康携带者。
- 基于细胞的NIPT未来可能成为绒毛膜绒毛取样的微创替代方案。
核心结论
- 基于细胞的NIPT可准确报告胎儿变异状态,并区分胎儿滋养层细胞与母体细胞。
- 未来基于细胞的NIPT可能为绒毛膜绒毛取样提供准确且侵入性更小的替代选择。
研究设计与样本
- 研究开发针对囊性纤维化的基于细胞的NIPT,并在一例单绒毛膜双胎妊娠中测试。
- 孕妇及其伴侣均为F508del杂合携带者,伴侣 additionally 阳性 for CFTR相关变异R117H。
- 从母血中利用抗体富集和毛细管拾取仪分离胎儿滋养层细胞。
主要发现
- 分离细胞的胎儿来源通过检测两个父源STR等位基因和Y染色体标志物验证,未检测到母体DNA污染。
- 直接变异分析检测到F508del杂合性,SNaPshot分析R117H仅检测到正常等位基因。
- 结果表明胎儿为F508del健康携带者,与传统产前检测结果一致。
临床怎么用
- 基于细胞的NIPT可用于有囊性纤维化风险的妊娠,准确判断胎儿变异状态。
- 该方法可区分胎儿滋养层细胞与母体细胞,减少母体污染干扰。
- 将来可能作为绒毛膜绒毛取样的微创替代方案用于产前诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to develop cell-based NIPT for cystic fibrosis (CF) and test a pregnancy at risk of two common pathogenic variants. METHOD: A pregnant woman carrying monozygotic twins opted for prenatal testing as she and her partner were heterozygote carriers of F508del (c.1521:1523del). The partner was also positive for the CFTR-related variant R117H (c.350G>A). Fetal trophoblasts from maternal blood were enriched and isolated using antibodies and a capillary-based cell-picking instrument. Multiplex PCR-based fragment length analysis was performed on the extracted fetal DNA for STR-genotyping, fetal gender and F508del variant status. The R117H variant status was tested using SNaPshot analysis. RESULTS: The fetal origin of the isolated cells was verified by detection of two paternally inherited STR alleles and an Y chromosome marker, while no maternal DNA contamination was detected. The direct variant analysis detected F508del heterozygosity and the SNaPshot analysis for R117H detected only the normal allele. Thus, the results showed that the fetuses were healthy carriers of F508del, concordant with the findings of conventional prenatal testing. CONCLUSION: Cell-based NIPT could accurately state the fetal variant status and distinguish fetal trophoblasts from maternal cells. In the future, cell-based NIPT may provide an accurate less invasive alternative to chorionic villous sampling.
引用
- Jeppesen LD, Hatt L, Singh R, et al. Cell-based non-invasive prenatal diagnosis in a pregnancy at risk of cystic fibrosis. Prenat Diagn. 2020. PMID: 33150588. doi:10.1002/pd.5861
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。